Cargando…
Aspirin-triggered 15-Epi-Lipoxin A(4) (LXA(4)) and LXA(4) Stable Analogues Are Potent Inhibitors of Acute Inflammation: Evidence for Anti-inflammatory Receptors
Lipoxins are bioactive eicosanoids that are immunomodulators. In human myeloid cells, lipoxin (LX) A(4) actions are mediated by interaction with a G protein–coupled receptor. To explore functions of LXA(4) and aspirin-triggered 5(S),6(R),15(R)-trihydroxy-7,9,13-trans-11-cis–eicosatetraenoic acid (15...
Autores principales: | Takano, Tomoko, Fiore, Stefano, Maddox, Jane F., Brady, Hugh R., Petasis, Nicos A., Serhan, Charles N. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2196289/ https://www.ncbi.nlm.nih.gov/pubmed/9151906 |
Ejemplares similares
-
Lipoxin (LX)A(4) and Aspirin-triggered 15-epi-LXA(4) Inhibit Tumor Necrosis Factor 1α–initiated Neutrophil Responses and Trafficking: Regulators of a Cytokine–Chemokine Axis
por: Hachicha, Mohamed, et al.
Publicado: (1999) -
Lipoxin A4 (LXA4) Reduces Alkali-Induced Corneal Inflammation and Neovascularization and Upregulates a Repair Transcriptome
por: He, Jiucheng, et al.
Publicado: (2023) -
Dynamic changes and clinical significance of LXA(4) in the perioperative period of cardiopulmonary bypass
por: Wu, Ming, et al.
Publicado: (2019) -
15-Epi-LXA(4) and MaR1 counter inflammation in stromal cells from patients with Achilles tendinopathy and rupture
por: Dakin, Stephanie G., et al.
Publicado: (2019) -
LXA4 Inhibits Lipopolysaccharide-Induced Inflammatory Cell Accumulation by Resident Macrophages in Mice
por: Mei, Hong-Xia, et al.
Publicado: (2021)